Midtrimester Dilation and Evacuation (D&E) Versus Prostaglandin induction: A Comparison of Composite Outcomes (Poster) by Whitley, Kari A, MD et al.
Lehigh Valley Health Network
LVHN Scholarly Works
Department of Obstetrics & Gynecology
Midtrimester Dilation and Evacuation (D&E)
Versus Prostaglandin induction: A Comparison of
Composite Outcomes (Poster)
Kari A. Whitley MD
Lehigh Valley Health Network
Meredith L. Rochon MD
Lehigh Valley Health Network, Meredith_L.Rochon@lvhn.org
Kevin Trinchere
Lehigh Valley Health Network, Kevin.Trinchere@lvhn.org
Wendy Prutsman MSN, CRNP
Lehigh Valley Health Network, wendy.prutsman@lvhn.org
Follow this and additional works at: http://scholarlyworks.lvhn.org/obstetrics-gynecology
Part of the Obstetrics and Gynecology Commons
This Poster is brought to you for free and open access by LVHN Scholarly Works. It has been accepted for inclusion in LVHN Scholarly Works by an
authorized administrator. For more information, please contact LibraryServices@lvhn.org.
Published In/Presented At
Whitley, K., Trinchere, K., Prutsman, W., Quiñones, J., & Rochon, M. (2011, February 7-12). Midtrimester Dilation and Evacuation
(D&E) Versus Prostaglandin Induction: A Comparison of Composite Outcomes. Poster presented at: The 31st Annual Meeting of the
Society for Maternal-Fetal Medicine, San Francisco, CA.
Midtrimester dilation and evacuation (D&E) versus prostaglandin induction:
A comparison of composite outcomes
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Maternal age (years) 32.8 ± 7.0 29.0 ± 6.2 <0.001
Ethnicity
    Caucasian 80% 73%
    Hispanic 11% 21% 0.25
    African American 1% 4%
    Other 9% 2%
Private Insurance 68% 54% 0.03
Multiparous 59% 57% 0.79
BMI (kg/m2) 27.7±6.7 28.8±6.7 0.19
GA at procedure (weeks) 17.4±3.0 19.7±2.3 <0.001
Previous uterine surgery 15% 14% 0.90
Previous LEEP/cone 6% 9% 0.52
Cervical ripening prior to 
procedure 86% 30% <0.001
Data in mean ± SD or %. D&E; dilation and evacuation. BMI; body mass 
index. GA; gestational age. LEEP; loop electrosurgical excision procedure.
Methods:
•  Retrospective cohort study 
•  Inclusion criteria: all patients having a planned 
midtrimester (13 0/7 weeks - 23 6/7 weeks) uterine 
evacuation at Lehigh Valley Health Network via 
either ultrasound-guided D&E or prostaglandin 
induction of labor from 1/2005 - 6/2010
•  Exclusion criteria: labor, chorioamnionitis, cervical 
insufficiency, advanced dilation, first or third 
trimester pregnancy
•  Patients were identified by both ICD 9 and 
diagnosis codes. Data was collected by review of 
medical records. 
•  Although both induction and D&E are safe methods for 
midtrimester uterine evacuation, D&E is associated with 
a lower composite complication rate, primarily due to 
a high rate of unplanned dilation and evacuation in the 
induction group. 
•  D&E may be more cost effective than prostaglandin 
induction of labor for midtrimester uterine evacuation 
due to significantly shorter length of stay.





Fetal Demise 23% 37% 0.03
Chromosomal or Genetic 
Abnormality 46% 11% <0.001
Structural Abnormality 27% 44% 0.13
Maternal Medical Condition 3% 1% 0.19
Other* 1% 15% <0.001
Data in %. *PPROM (preterm premature rupture of membranes), 
oligohydramnios, growth restriction, or viral infection.
Table 2.  Primary Indication for Uterine Evacuation
Objective:
To determine the optimal procedure for midtrimester uterine 
evacuation.
Study Design:
We performed a retrospective cohort study of all women 
undergoing a planned midtrimester (13 0/7 weeks to 23 6/7 
weeks) uterine evacuation procedure at our institution from 
1/2005 - 6/2010. Women undergoing D&E by an experienced 
provider under continuous ultrasound guidance were 
compared with those undergoing a prostaglandin induction. 
Women in labor or with cervical insufficiency were excluded. 
Medical records were reviewed for maternal demographics, 
comorbidities, procedure indications and complications. 
The primary outcome was a composite complication rate, 
defined as any one of the following events: infection, 
transfusion, need for additional surgery, unexpected 
admission or readmission to the hospital or uterine/cervical 
injury. Student t test, chi square, Mann U Whitney, and 
Fisher’s exact test were used as indicated.
Results:
221 women were identified: 94 D&E and 127 induction. 
Indications for uterine evacuation included termination for 
fetal abnormalities (58%), fetal demise (31%), and other 
(11%). Women undergoing D&E were older (32.8±7.0 v. 
29.0±6.2 yrs, p<0.001), had an earlier gestational age 
(17.4±3.0 v. 19.7±2.3 wks, p<0.001), and were more likely to 
have cervical ripening prior to the procedure (86% v. 30%, 
p<0.001). There was no difference in parity, insurance class, 
BMI, and rate of previous uterine surgery. The composite 
complication rate was higher in the induction group (15% v. 
28%, p=0.03), although serious complications were rare in 
both groups (7% v. 3%, p=0.15). Median length of stay was 
significantly shorter in the D&E group (5.7 hrs, range 2.6 - 
241.7 hrs vs. 28.4 hrs, range 11.0 - 173.0 hrs, p<0.001).
Conclusion: 
Our data suggest that midtrimester D&E is safer and more 
cost effective than prostaglandin induction. While there are 
many factors that influence provider and patient preference, 
from a systems perspective, D&E may be preferable to 





Composite Complication Rate* 14 (15%) 35 (28%) 0.03
Serious Complication Rate** 7 (7%) 4 (3%) 0.15
EBL>500 13 (14%) 8 (6%) 0.06
Transfusion 1 (1%) 2 (2%) 0.75
Chorioamnionitis 4 (4%) 10 (8%) 0.28
Additional surgery required
    Dilation and curettage
     Repair of cervical laceration










Readmission 2 (2%) 2 (2%) 0.76
Length of Stay (median hours) 5.7 (2.6-241.7) 28.4 (11.0-173.0) <0.001
Data is in n (%) or median (range), as indicated. EBL, estimated blood loss.
* Composite Complication Rate - hemorrhage (EBL>500), transfusion, chorioamnionitis, 
need for additional surgery, unexpected admission or readmission.
** Serious Complication rate - transfusion, repair of uterine injury, readmission.
Table 3.  Procedure Outcome and Complications
• Composite complication rate:
	 	 -	 	Cervical,	uterine,	or	intraabdominal	injury
	 	 -	Fever
	 	 -	 	Hemorrhage	(EBL>500)
	 	 -	 	Transfusion
	 	 -	 	Need	for	additional	surgery	(cervical	repair,	uterine	
curettage,	hysterectomy,	laparotomy)
	 	 -	 	Need	for	additional	antibiotics
	 	 -	 	Unexpected	admission	or	readmission
	 	 -	 	Maternal	death
•  Serious complications were defined as transfusion, 
uterine injury (cervical laceration, perforation),  
readmission and maternal death
